Narcotic drugs introduction Domina Petric MD Narcotic drugs

  • Slides: 10
Download presentation
Narcotic drugs introduction Domina Petric, MD

Narcotic drugs introduction Domina Petric, MD

Narcotic drugs and dopamine Mesolimbic dopaminergic system is the main target for narcotic drugs.

Narcotic drugs and dopamine Mesolimbic dopaminergic system is the main target for narcotic drugs. Ventral tegmental area (VTA) sends projections into the nucleus accumbens, amygdala, hippocampus and prefrontal cortex. Most of the VTA neurons excrete dopamine. Dopamine release in the mesolimbic dopaminergic system is very important for reward and motivation processing.

Image source: QUORA Dopamine pathways: Nucleus accumbens VTA Reward Motivation Pleasure Euphoria Motor functioning

Image source: QUORA Dopamine pathways: Nucleus accumbens VTA Reward Motivation Pleasure Euphoria Motor functioning Compulsion Perseveration

Narcotic drugs and dopamine Narcotic drugs activate mesolimbic dopaminergic system (MDS). MDS is important

Narcotic drugs and dopamine Narcotic drugs activate mesolimbic dopaminergic system (MDS). MDS is important in discernment between expected and real reward. MDS creates strong signal for learning process.

Narcotic drugs classification Narcotic drugs that bind on the Gio-protein receptors. Narcotic drugs that

Narcotic drugs classification Narcotic drugs that bind on the Gio-protein receptors. Narcotic drugs that act on the ionotropic receptors or ion channels. Narcotics that affect dopaminergic transporter (DTA).

Tolerance Dose of narcotic drugs must be increased to maintain rewarding effect. This is

Tolerance Dose of narcotic drugs must be increased to maintain rewarding effect. This is called tolerance. Very fast development of tolerance is called tachyphylaxis.

Abstinence syndrome After cessation of taking narcotic drug, usually after relatively short period of

Abstinence syndrome After cessation of taking narcotic drug, usually after relatively short period of time (specific for every drug), abstinence syndrome develops.

Addiction It is characterised with high motivation to get the narcotic drug despite negative

Addiction It is characterised with high motivation to get the narcotic drug despite negative consequences. With time drug abuse becomes compulsive (desire without pleasure).

LTP: long term potentiation, activation of NMDA receptors. LTP Nucleus accumbens Dopamine Addiction High

LTP: long term potentiation, activation of NMDA receptors. LTP Nucleus accumbens Dopamine Addiction High risk for relapses Genetic predisposition

Katzung, Masters, Trevor. Clinical pharmacology.

Katzung, Masters, Trevor. Clinical pharmacology.

Substance Abuse Drugs of abuse Narcotic Non narcoticSubstance Abuse Drugs of abuse Narcotic Non narcotic
Antihypertensive drugs for primary care physician DOMINA PETRICAntihypertensive drugs for primary care physician DOMINA PETRIC
Domina Petric MD Drugs that act on ionotropicDomina Petric MD Drugs that act on ionotropic
Clinical pharmacology of antiseizure drugs Domina Petric MDClinical pharmacology of antiseizure drugs Domina Petric MD
Drugs used in generalized seizures Domina Petric MDDrugs used in generalized seizures Domina Petric MD
Drugs that activate Gioproteins receptors Domina Petric MDDrugs that activate Gioproteins receptors Domina Petric MD
Introduction to motor systems Domina Petric MD IntroductionIntroduction to motor systems Domina Petric MD Introduction
Analgesics Narcotic Analgesics Non Narcotic Analgesics Comparison ofAnalgesics Narcotic Analgesics Non Narcotic Analgesics Comparison of
NARCOTIC ANALGESICS I Blanton Narcotic refers to narcosisstuporNARCOTIC ANALGESICS I Blanton Narcotic refers to narcosisstupor